2020 Highlights on Anti-Androgens in High-Risk PC: Does ADT+Abiraterone Combo Improve OS? How Does the Addition of Olaparib After Docetaxel Affect PFS?
By
Yale Cancer Center
FEATURING
Daniel Petrylak
By
Yale Cancer Center
FEATURING
Daniel Petrylak
Login to view comments.
Click here to Login